| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.36 | 8e-17 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-14 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |